HKG:6821 Market Cap

HKG:6821 has a market cap or net worth of 34.63 billion as of July 3, 2025. Its market cap has increased by 25.32% in one year.

Market Cap

34.63B

Enterprise Value

26.42B

Revenue

6.38B

Ranking

n/a

PE Ratio

32.51

Stock Price

82.75

Market Cap Chart

Since November 18, 2016, HKG:6821's market cap has increased from 5.59B to 34.63B, an increase of 519.42%. That is a compound annual growth rate of 23.53%.

Market Cap History

Date	Market Cap	% Change
Jul 4, 2025	34.63B	24.02%
Dec 31, 2024	27.92B	-38.76%
Dec 29, 2023	45.59B	-23.48%
Dec 30, 2022	59.58B	-56.36%
Dec 31, 2021	136.53B	58.47%
Dec 31, 2020	86.15B	157.03%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines	227.18B
Hansoh Pharmaceutical Group Company	180.75B
Innovent Biologics	139.72B
JD Health International	134.24B
WuXi Biologics	104.97B
Sino Biopharmaceutical	97.47B
Akeso	95.23B
CSPC Pharmaceutical Group	94.18B

Market Cap Rankings